DPHARM: Disruptive Innovations to Modernize Clinical Research’s Post

At Covariate, we've delved into 2023 data on US/EU biotech & pharma landscape. In a series of posts, we'll spotlight key trends, top players, and standout institutions in clinical trials, life science research, and the patent arena. 🚀 Let's kick off with clinical trials (1) In 2023, we saw 33,578 trials initiated (first patient, first visit). Interestingly, this marks the lowest count since 2019. The decline is linked to a) a conservative market shift in 2022-2023, favoring more stable assets over clinical research, and b) an outlier spike in US/EU clinical trial activity during the 2020-2022 COVID-19 pandemic. Stay tuned for more insights into the dynamic world of biotech and pharma! 💡 #ClinicalTrials #Biotech #Pharma #insights #healthcare #medtech

Join senior execs including Steve Rosenberg, Bruce Hellman, Florence Mowlem, PhD, Andrea Valente and Don Butler at #pharma and #lifesciences events this fall.  Learn how we’re guiding #pharma and #biotech sponsors, sites and patients to demand more from #clinicalresearch technology with modern #eCOA #ePRO and best-in-class #eConsent to improve #clinicaltrials and #realworldstudies. https://lnkd.in/g_j4kDwn DPHARM: Disruptive Innovations to Modernize Clinical Research Society for Clinical Research Sites (SCRS) Society for Clinical Data Management (SCDM) Outsourcing in Clinical Trials Event Series CNS Summit

⭐ At #ComacMedical, we specialize in delivering comprehensive clinical trials planning and design services tailored to meet your research objectives. As a trusted #CRO and #SMO, we understand the critical importance of strategic trial planning and design in achieving successful outcomes. Today, we focus on: 🔍 Concept Sheet & Protocol Development: We transform innovative ideas into solid clinical protocols, ensuring your trial has a scientifically sound foundation. 🔍 Study Design Elements: Our expertise in study design ensures optimal randomization, endpoint definition, and accurate sample size calculations. From defining research questions to performing power analyses, our expert team is dedicated to guiding you through every step of the clinical trial process. Watch the video to learn more about how we can support your clinical trials with precision and expertise. 🎥✨ #ClinicalTrials #Research #HealthcareInnovation #ClinicalResearch #StudyDesign #ResearchExcellence #Biotech #Pharma

TrialKey.ai (ASX: OPL) will be at the 7th Annual Bio Connections Australia by Informa on 29th July 2024 at the Crown Promenade Melbourne! Bio Connections Australia is a premier event in the biotech industry, providing a unique platform for networking, discussion, and thought leadership. The conference focuses on translating medical research into commercialisation, drug discovery and development, early phase clinical trials, and expediting Australia’s great science into commercialisation. We have some exciting sessions lined up: - Saurabh Jain, our Executive Chairman, will be giving a talk on ‘Why Almost All Clinical Trials Will Occur in the AI World’ - Damon Rasheed, our CTO, will be a panelist on ‘Achieving Scale in World's Best Practice in Development in the Next 5-10 Years: What Would This Take?’ together with with Felicia Pradera (Head – Health Security Systems Australia, DMTC Limited), Anand Gautam (Founder, G2OME Consulting), Dr Amanda Buttery GAICD (Director, Integrated Evidence, Medical Affairs, Moderna), moderated by Craig Rayner (Director, Moderna's Regional Research Centre for Respiratory Medicines and Tropical Diseases) We invite everyone to visit our booth at the event, where our Business Development Manager, Minh-Thu Cao Xuan will be conducting demos of the TrialKey platform. Looking forward to seeing you there! Book a demo: https://lnkd.in/g9rJtUBm #trialkey #opyl #medtech #biotech #clinicalresearch #medicalresearch #medicalinnovation #clinicaltrials #pharmaceutical #research

"Excited to have been a part of the 42nd SPSR International Webinar on #ArtificialIntelligence applications in the #pharma industry! 🤖 As we celebrated National Pharmacy Education Day, March 03, 2024, it was truly mind-blowing to see how AI is revolutionizing the way we approach drug discovery, clinical trials, and patient care. 🧠 The future is here, and it's powered by technology. 💊 Thank you SPSR for organizing such an informative and thought-provoking event....! #SPSRWebinar #PharmaIndustry #Innovation #FutureOfMedicine"

Great insights from Rui Rui Zhang Xiang at the 21st BioPharma Clinical Trials Nexus! Her emphasis on innovation and adaptive approaches is crucial for navigating the evolving landscape of clinical trials. Stay tuned for more valuable takeaways!

At the recent German Network for Personalised Medicine (DNPM) congress, Josef Hecken, chairman of the Federal Joint Committee (G-BA), shared key shared innovative approaches to evidence generation and patient care, signalling a shift from traditional drug trials. This could mean easier access to personalised therapies, benefiting both patients and manufacturers. 🏥 Dive into the details and implications of this transformative change in our latest insider insight ➡ 🔗 https://lnkd.in/evj6naTn #MarketAccess #PatientAccess #PersonalisedMedicine #HealthcareInnovation #DrugTrials #Pharma #Biotech #PatientCare * 𝒘𝒓𝒊𝒕𝒕𝒆𝒏 𝒃𝒚 Manahill Baig

#RealWorldData can be your prescription for commercial drug success! How❓ Really enjoyed sharing a panel discussion at LSX - partnering for Life Science eXecutives event with Anders Borglykke (Novo Nordisk), Nicole Mather (IBM) and Marc Jones (Altoida, Inc.) where we shared examples how #RWD can accelerate drug development but also support your launch and commercial success. 👉insillico drug development, which algorithms should used large amounts of objective quality RWD 👉external clinical trial control arms such as historic controls or synthetic, again using large amount of health data 👉#digitalbiomarkers using sensors to capture data At Ypsomed AG we integrate connected injection devices with therapy management solutions to support patients for #selfcare, but also generating robust and objective data to support Pharma commercial success.

Are you ready to revolutionize your approach to asset development? Join us at 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝟐𝟎𝟐𝟒 in beautiful Basel, Switzerland, on 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟗, 𝟐𝟎𝟐𝟒, from 𝟏𝟏 𝐚.𝐦. 𝐭𝐨 𝟑 𝐩.𝐦. 𝐂𝐄𝐒𝐓. This is your chance to engage with industry experts and discover how integrated CDMO and CRO services can drive speed, simplicity, and scalability in your clinical trials. Dive into discussions about the latest advancements in technology and patient-centric strategies that are shaping the future of therapeutics. Hear firsthand updates from Thermo Fisher Scientific, along with impactful case studies that highlight real-world success stories. 𝐃𝐨𝐧’𝐭 𝐦𝐢𝐬𝐬 𝐨𝐮𝐭—𝐬𝐩𝐚𝐜𝐞 𝐢𝐬 𝐥𝐢𝐦𝐢𝐭𝐞𝐝! 𝐑𝐞𝐬𝐞𝐫𝐯𝐞 𝐲𝐨𝐮𝐫 𝐬𝐞𝐚𝐭 𝐭𝐨𝐝𝐚𝐲 𝐚𝐧𝐝 𝐛𝐞 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐡𝐚𝐧𝐠𝐞. 👉 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐍𝐨𝐰:  https://lnkd.in/gtTxbb2N #PartnershipInsights #ClinicalTrials #Therapeutics #Innovations #PatientCentricity #CDMO #CRO #Basel2024 #Healthcare #Pharma #Networking #Technology #FutureOfHealthcare #Collaboration #ClinicalResearch #ThermoFisher

In #drugdevelopment, there is a critical need to innovate beyond mere computational enhancements and adopt a holistic approach that ensures the entire drug development process is geared towards achieving successful clinical outcomes. Learn how AtlasGEN Novel Drug Designer accomplishes this in our latest white paper: https://hubs.li/Q02DMjK_0